SurModics (SRDX) Price & Analysis

Compare

117 Followers

SRDX Stock Chart & Stats

$28.13

$0.05(0.12%)

At close: Jan 08 4:00 PM EST

$28.13

$0.05(0.12%)

Day’s Range― - ―

52-Week Range$25.87 - $43.00

Previous CloseN/A

Volume44.36K

Average Volume (3M)690.97K

Market Cap

$614.51M

Enterprise ValueN/A

Total Cash (Recent Filing)$32.73M

Total Debt (Recent Filing)$32.58M

Price to Earnings (P/E)―

Beta0.53

Next Earnings

Feb 10, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding13,491,000

10 Day Avg. Volume1,540,720

30 Day Avg. Volume690,968

Financial Highlights & Ratios

PEG Ratio-0.07

Price to Book (P/B)4.62

Price to Sales (P/S)4.35

P/FCF Ratio-169.19

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusModerate Sell

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Acquisition ApprovalDistrict Court Judge Jeffrey Cummings ruled against the preliminary injunction sought by the FTC, allowing the proposed acquisition of Surmodics by GTCR to move forward.

Investor ConfidenceThere is an expectation that SRDX stock will rally towards $43 per share following the court's decision, indicating investor confidence.

Market PositionThe Judge found the FTC's argument about the coatings market unpersuasive, suggesting a more favorable market position for Surmodics.

Bears Say

Analyst RatingDespite the legal victory, the analyst maintains a MARKET PERFORM rating as the expected rally towards $43 per share is not seen as investable.

SurModics News

Surmodics’ acquisition will not be appealed by FTC

Surmodics (SRDX) expects to close its previously announced its acquisition by an affiliate of GTCR promptly. The Federal...

12d ago

SRDX

Surmodics downgraded to Underperform from Market Perform at Barrington

Barrington analyst Michael Petusky downgraded Surmodics (SRDX) to Underperform from Market Perform given that shares are now trading...

15d ago

SRDX

Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance

The major averages were mixed near noon, with the S&P 500 and Nasdaq in negative territory amid declines...

18d ago

Morning Movers: Nvidia dips after SoftBank sells out of stake

Stock futures are leveling off. Global equities rose on signs that the United States federal government shutdown may...

18d ago

Surmodics confirms District Court denies request for preliminary injunction

Surmodics (SRDX) “announced that the United States District Court for the Northern District of Illinois has denied a...

18d ago

SRDX

Surmodics acquisition by GTCR can proceed, Reuters reports

Private equity firm GTCR will be allowed to move forward with its acquisition of medical device coatings maker...

19d ago

ITGR

SRDX

SurModics trading halted, news pending

14:45 EST SurModics (SRDX) trading halted, news pending Published first on TheFly – the ultimate source for real-time,...

19d ago

SRDX

Surmodics’ Pounce thrombectomy platform shows efficacy in limb ischemia study

Surmodics (SRDX) announced that results from an analysis of 160 real-world patients with symptomatic infrainguinal limb ischemia from...

25d ago

SRDX

SurModics Completes Merger, Ends Credit Agreement

An update from SurModics ( ($SRDX) ) is now available. On November 19, 2025, SurModics completed a merger...

10d ago

SRDX

SurModics Merger with GTCR LLC Clears Legal Hurdle

An announcement from SurModics ( ($SRDX) ) is now available. On November 10, 2025, Surmodics, Inc. announced that...

17d ago

SRDX

SRDX Earnings Report this Week: Is It a Buy, Ahead of Earnings?

SurModics Inc (SRDX) is scheduled to report 4th quarter earnings on 11/05/2025. Regarding Q4 estimates, Wall Street analysts...

26d ago

SRDX

Surmodics announces results from PROWL registry study

The company states: “Surmodics (SRDX) announced that results from a sex-specific analysis of 160 real-world acute, subacute, and...

1M ago

SRDX

SurModics: Hold Rating Amid Mixed Financial Performance and Legal Uncertainties

Barrington analyst Michael Petusky has maintained their neutral stance on SRDX stock, giving a Hold rating on August...

4M ago

SRDX

SurModics: Balancing Strong Financial Performance with Acquisition Uncertainty

Needham analyst Michael Matson has maintained their neutral stance on SRDX stock, giving a Hold rating on July...

4M ago

SRDX

SRDX FAQ

What was SurModics Inc’s price range in the past 12 months?

SurModics Inc lowest stock price was $25.87 and its highest was $43.00 in the past 12 months.

What is SurModics Inc’s market cap?

SurModics Inc’s market cap is $614.51M.

When is SurModics Inc’s upcoming earnings report date?

SurModics Inc’s upcoming earnings report date is Feb 10, 2026 which is in 73 days.

How were SurModics Inc’s earnings last quarter?

Currently, no data Available

Is SurModics Inc overvalued?

According to Wall Street analysts SurModics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does SurModics Inc pay dividends?

SurModics Inc does not currently pay dividends.

What is SurModics Inc’s EPS estimate?

SurModics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does SurModics Inc have?

SurModics Inc has 13,491,000 shares outstanding.

What happened to SurModics Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of SurModics Inc?

Currently, no hedge funds are holding shares in SRDX

SurModics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-15.36%

Trailing 12-Months

Asset Growth

-4.28%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

SurModics Inc

SurModics, Inc. (SRDX) is a leading provider of medical device and in vitro diagnostic technologies, primarily serving the healthcare industry. The company specializes in developing innovative coating technologies, drug delivery systems, and biomaterials, which are used in various applications such as cardiovascular, ophthalmology, and other specialty markets. SurModics focuses on enhancing the performance and safety of medical devices through its advanced product offerings and services, aimed at improving patient outcomes.

SurModics (SRDX) Earnings & Revenues

Historic Earnings Reports

SRDX Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"$26","30":"$30","34":"$34","38":"$38","42":"$42"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,30,34,38,42],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.44,27.790769230769232,28.141538461538463,28.492307692307694,28.843076923076925,29.193846153846156,29.544615384615383,29.895384615384614,30.246153846153845,30.596923076923076,30.947692307692307,31.298461538461538,31.64923076923077,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.44,25.32923076923077,23.21846153846154,21.10769230769231,18.99692307692308,16.886153846153846,14.775384615384617,12.664615384615386,10.553846153846155,8.443076923076926,6.332307692307694,4.2215384615384615,2.1107692307692325,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.44,27.790769230769232,28.141538461538463,28.492307692307694,28.843076923076925,29.193846153846156,29.544615384615383,29.895384615384614,30.246153846153845,30.596923076923076,30.947692307692307,31.298461538461538,31.64923076923077,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":41.9,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.31,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.63,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":39.6,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":32.86,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.89,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.47,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.03,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":34.34,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":29.91,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":27.44,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >